EP1076090A3 - ESTs and encoded human proteins - Google Patents

ESTs and encoded human proteins

Info

Publication number
EP1076090A3
EP1076090A3 EP00202699.5A EP00202699A EP1076090A3 EP 1076090 A3 EP1076090 A3 EP 1076090A3 EP 00202699 A EP00202699 A EP 00202699A EP 1076090 A3 EP1076090 A3 EP 1076090A3
Authority
EP
European Patent Office
Prior art keywords
ests
human proteins
encoded human
encoded
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP00202699.5A
Other languages
German (de)
French (fr)
Other versions
EP1076090A2 (en
EP1104808A1 (en
Inventor
Jean-Baptiste Dumas Milne Edwards
Severin Jobert
Jean-Yves Giordano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Biodevelopment SAS
Original Assignee
Genset SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genset SA filed Critical Genset SA
Priority to EP04078018A priority Critical patent/EP1541683A1/en
Publication of EP1076090A2 publication Critical patent/EP1076090A2/en
Publication of EP1076090A3 publication Critical patent/EP1076090A3/en
Publication of EP1104808A1 publication Critical patent/EP1104808A1/en
Ceased legal-status Critical Current

Links

EP00202699A 1999-08-05 2000-07-27 ESTs and encoded human proteins Ceased EP1104808A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP04078018A EP1541683A1 (en) 1999-08-05 2000-07-27 ESTs and encoded human proteins

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14749999P 1999-08-05 1999-08-05
US147499P 1999-08-05

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP04078018A Division EP1541683A1 (en) 1999-08-05 2000-07-27 ESTs and encoded human proteins

Publications (3)

Publication Number Publication Date
EP1076090A2 EP1076090A2 (en) 2001-02-14
EP1076090A3 true EP1076090A3 (en) 2001-03-21
EP1104808A1 EP1104808A1 (en) 2001-06-06

Family

ID=22521809

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00202699A Ceased EP1104808A1 (en) 1999-08-05 2000-07-27 ESTs and encoded human proteins

Country Status (4)

Country Link
US (2) US6639063B1 (en)
EP (1) EP1104808A1 (en)
JP (1) JP2002010789A (en)
CA (1) CA2311201A1 (en)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1073739B1 (en) * 1998-04-29 2006-12-27 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Cd40-interacting and traf-interacting proteins
US20030166132A1 (en) * 1998-08-26 2003-09-04 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
GB9820002D0 (en) * 1998-09-14 1998-11-04 Smithkline Beecham Biolog Novel compounds
US7465785B2 (en) * 1999-03-08 2008-12-16 Genentech, Inc. Polypeptide encoded by a nucleic acid over-expressed in melanoma
NZ527292A (en) * 1999-03-23 2005-03-24 Genentech Inc Secreted and transmembrane polypeptides PRO1484 and nucleic acids encoding the same, with homology to an adipocyte complement-related protein
US20030211510A1 (en) 1999-06-30 2003-11-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20020172952A1 (en) * 1999-06-30 2002-11-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US7408047B1 (en) * 1999-09-07 2008-08-05 Amgen Inc. Fibroblast growth factor-like polypeptides
US7459540B1 (en) 1999-09-07 2008-12-02 Amgen Inc. Fibroblast growth factor-like polypeptides
US6875854B1 (en) * 1999-11-18 2005-04-05 The Brigham And Women's Hospital, Inc. Compositions and methods for the improved diagnosis and treatment of germ cell tumors
US6716626B1 (en) * 1999-11-18 2004-04-06 Chiron Corporation Human FGF-21 nucleic acids
US20030054513A1 (en) * 2000-01-28 2003-03-20 Gregory Donoho Novel human enzymes and polynucleotides encoding the same
AU2001232275A1 (en) * 2000-02-14 2001-08-20 Bf Research Institute, Inc. Novel collagen-like protein clac, precursor thereof and genes encoding the same
US20020107190A1 (en) * 2000-02-25 2002-08-08 Chung Ching Ming Novel genes and expression products therefrom
US20040005578A1 (en) * 2000-04-27 2004-01-08 Yoji Yamada Myocardial cell proliferation-associated genes
JP2004530629A (en) * 2000-06-07 2004-10-07 バイオシネクサス インコーポレーテッド Immunostimulatory RNA / DNA hybrid molecule
US7355023B2 (en) * 2000-06-29 2008-04-08 Duke University Isolated nucleic acids and polypeptides associated with glucose homeostasis disorders and method of detecting the same
JP2002142765A (en) * 2000-07-14 2002-05-21 Tosoh Corp New method for analyzing genom
US7335732B2 (en) * 2000-08-01 2008-02-26 Genentech, Inc. PRO9799 polypeptides
US7442765B2 (en) * 2000-08-24 2008-10-28 Genentech, Inc. Secreted transmembrane polypeptides and nucleic acids encoding the same
DK1334123T3 (en) * 2000-11-09 2009-01-12 Cenix Bioscience Gmbh Eukaryotic cell division genes and their use in the diagnosis and treatment of proliferative diseases
US7220844B2 (en) * 2000-12-14 2007-05-22 Wisconsin Alumni Research Foundation Liver tumor marker sequences
WO2002060466A2 (en) * 2001-02-02 2002-08-08 Genset S.A. Gssp3 polynucleotides and polypeptides and uses thereof
US7601825B2 (en) 2001-03-05 2009-10-13 Agensys, Inc. Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
US20120076789A1 (en) * 2001-02-08 2012-03-29 Agensys, Inc. Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer
US6924358B2 (en) * 2001-03-05 2005-08-02 Agensys, Inc. 121P1F1: a tissue specific protein highly expressed in various cancers
CA2443123A1 (en) * 2001-04-10 2002-10-24 Agensys, Inc. Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
US20030022205A1 (en) * 2001-05-09 2003-01-30 Millennium Pharmaceuticals, Inc. 98359, a sodium channel beta 4 subunit, and uses therefor
US7157558B2 (en) * 2001-06-01 2007-01-02 Genentech, Inc. Polypeptide encoded by a polynucleotide overexpresses in tumors
US20030104385A1 (en) * 2001-08-02 2003-06-05 Evans Glen A. Nucleic acids and encoded polypeptides associated with bipolar disorder
GB0118995D0 (en) 2001-08-03 2001-09-26 Univ Wales Medicine Detection of mutations in nucleic acids
EP1423708B1 (en) * 2001-09-07 2006-11-29 Genfit Compositions and methods for aa4rp assay
JP2005504534A (en) 2001-09-19 2005-02-17 アメリカ合衆国政府 Transductin-1 and transductin-2 and application to hereditary hearing impairment
US20060088828A1 (en) * 2002-01-23 2006-04-27 Harris Peter C Polycystic kidney disease nucleic acids and proteins
AT500282A3 (en) * 2002-03-28 2006-06-15 Jsw Res Forschungslabor Gmbh NEUROTROPHIC AND NEUROPROTECTIVE PEPTIDES
MXPA04009959A (en) * 2002-04-12 2004-12-13 Schering Corp G-protein coupled receptor ligands and methods.
US7038030B2 (en) * 2002-04-16 2006-05-02 University Of South Florida BIVM (basic, immunoglobulin-like variable motif-containing) gene, transcriptional products, and uses thereof
ES2307933T3 (en) * 2002-04-26 2008-12-01 Astellas Pharma Inc. 35 KDA PROTEIN.
EP1572921A2 (en) * 2002-05-07 2005-09-14 Immunex Corporation Cytokine polypeptides
EP2332956A1 (en) * 2002-07-08 2011-06-15 Genentech, Inc. Antibody binding to PRO71238
CN1681834A (en) * 2002-08-14 2005-10-12 株式会社Lg生命科学 Gene families associated with liver cancer
TW200413539A (en) * 2002-09-30 2004-08-01 Oncotherapy Science Inc Genes and polypeptides relating to prostate cancers
GB0308241D0 (en) * 2003-04-10 2003-05-14 Univ Wales Medicine Screening methods and sequences relating thereto
EP1626986A2 (en) * 2003-05-16 2006-02-22 Genova Ltd. Secreted polypeptide species associated with cardiovascular disorders
WO2006031210A1 (en) 2003-05-29 2006-03-23 Board Of Regents, The University Of Texas Systems Jabi as a prognostic marker and a therapeutic target for human cancer
WO2009114733A2 (en) * 2008-03-13 2009-09-17 Ceres, Inc. Nucleotide sequences and corresponding polypeptides conferring modulated growth rate and biomass in plants grown in saline and oxidative conditions
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
US7485430B2 (en) 2004-04-15 2009-02-03 The Curators Of The University Of Missouri Methods and compositions for evaluation of fertility
EP2518510A1 (en) * 2004-04-20 2012-10-31 SphingoTec GmbH Use of precursors of tachykinins and/or their fragments in medical diagnostic
US7892733B1 (en) 2004-04-22 2011-02-22 Amgen Inc. Response element regions
US8017344B2 (en) 2004-04-28 2011-09-13 Eisai R&D Management Co., Ltd. Methods for detecting Th1 cells
CN101084496B (en) * 2004-05-04 2012-11-21 波士顿咨询集团公司 Method and apparatus for selecting, analyzing, and visualizing related database records as a network
WO2005114222A1 (en) * 2004-05-13 2005-12-01 Sphingo Tec Gmbh Use of precursors of enkephalins and/or their fragments in medical diagnostics
EP1751299B1 (en) * 2004-05-26 2010-01-27 Anima Cell Metrology Methods for evaluating ribonucleotide sequences
US20060008875A1 (en) * 2004-07-06 2006-01-12 Universitair Medisch Centrum Rotterdam Novel TFIIH subunit
US7670776B1 (en) 2004-07-22 2010-03-02 Myriad Genetics, Inc. MYH gene variants and use thereof
US7563571B1 (en) 2004-07-22 2009-07-21 Myriad Genetics, Inc. MYH gene variants and use thereof
GB0417887D0 (en) * 2004-08-11 2004-09-15 Ares Trading Sa Protein
EP1804830A2 (en) * 2004-09-08 2007-07-11 The Ludwig Institute for Cancer Research Cancer-testis antigens
US20070172843A1 (en) * 2005-09-12 2007-07-26 Conrad Susan E MEK interacting protein 1 as diagnostic and therapeutic target for breast cancer treatment and prevention
US7723052B2 (en) 2006-05-11 2010-05-25 Quark Pharmaceuticals, Inc. Screening systems utilizing RTP801
EP2026843A4 (en) 2006-06-09 2011-06-22 Quark Pharmaceuticals Inc Therapeutic uses of inhibitors of rtp801l
US8751479B2 (en) * 2007-09-07 2014-06-10 Brand Affinity Technologies, Inc. Search and storage engine having variable indexing for information associations
WO2009047760A2 (en) 2007-10-09 2009-04-16 Anima Cell Metrology, Inc. Systems and methods for measuring translation activity in viable cells
US8614311B2 (en) 2007-12-12 2013-12-24 Quark Pharmaceuticals, Inc. RTP801L siRNA compounds and methods of use thereof
JOP20190083A1 (en) 2008-06-04 2017-06-16 Amgen Inc Fgf21 mutant fusion polypeptides and uses thereof
EP2358749B1 (en) 2008-10-10 2018-07-18 Amgen, Inc Fgf21 mutants and uses thereof
WO2010099472A2 (en) 2009-02-27 2010-09-02 The U.S.A. Of America, As Represented By The Secretary, Department Of Health And Human Services Spanx-b polypeptides and their use
DK3248610T3 (en) * 2009-05-05 2024-01-15 Amgen Inc FGF21 MUTANTS AND USES THEREOF
AU2010246038A1 (en) 2009-05-05 2011-12-01 Amgen Inc. FGF21 mutants and uses thereof
EP2443145A1 (en) * 2009-06-17 2012-04-25 Amgen, Inc Chimeric fgf19 polypeptides and uses thereof
WO2011036666A2 (en) 2009-09-24 2011-03-31 Anima Cell Metrology, Inc. Systems and methods for measuring translation of target proteins in cells
AU2010326024A1 (en) * 2009-12-02 2012-07-05 Amgen Inc. Binding proteins that bind to human FGFR1c, human beta-Klotho and both human FGFR1c and human beta-Klotho
UA109888C2 (en) 2009-12-07 2015-10-26 ANTIBODY OR ANTIBODILITY ANTIBODY OR ITS BINDING TO THE β-CLOTE, FGF RECEPTORS AND THEIR COMPLEXES
WO2011103567A2 (en) * 2010-02-22 2011-08-25 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Peptides and methods for inducing cell death
EP2558497A2 (en) 2010-04-15 2013-02-20 Amgen Inc. Human fgf receptor and beta-klotho binding proteins
EP2571513B1 (en) * 2010-05-17 2016-09-07 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases
CN103096914B (en) 2010-05-17 2015-08-12 Atyr医药公司 The innovation of the treatment relevant to the protein fragments of Leucyl-tRNA synthetase, diagnosis and antibody compositions finds
JP2012100557A (en) * 2010-11-08 2012-05-31 Institute Of Physical & Chemical Research Novel gene, and osteoporosis testing method based on single nucleotide polymorphism on fong gene locus
US8715995B2 (en) * 2011-11-18 2014-05-06 Novozymes A/S Polypeptides having beta-glucosidase activity and beta-xylosidase activity and polynucleotides encoding same
EP2780449B1 (en) 2011-11-18 2018-04-11 Novozymes, Inc. Polypeptides having beta-glucosidase activity, beta-xylosidase activity, or beta-glucosidase and beta-xylosidase activity and polynucleotides encoding same
EP2833892A4 (en) 2012-04-02 2016-07-20 Moderna Therapeutics Inc Modified polynucleotides for the production of oncology-related proteins and peptides
WO2013151666A2 (en) 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of biologics and proteins associated with human disease
JP6144355B2 (en) 2012-11-26 2017-06-07 モデルナティエックス インコーポレイテッドＭｏｄｅｒｎａＴＸ，Ｉｎｃ． Chemically modified mRNA
JP2016504050A (en) 2013-01-17 2016-02-12 モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． Signal sensor polynucleotide for modification of cell phenotype
WO2014159813A1 (en) 2013-03-13 2014-10-02 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
EP3971287A1 (en) 2013-07-11 2022-03-23 ModernaTX, Inc. Compositions comprising synthetic polynucleotides encoding crispr related proteins and synthetic sgrnas and methods of use
US20160194368A1 (en) 2013-09-03 2016-07-07 Moderna Therapeutics, Inc. Circular polynucleotides
AU2014315287A1 (en) 2013-09-03 2015-03-12 Moderna Therapeutics, Inc. Chimeric polynucleotides
US10323076B2 (en) 2013-10-03 2019-06-18 Modernatx, Inc. Polynucleotides encoding low density lipoprotein receptor
CA2955250A1 (en) 2014-07-16 2016-01-21 Moderna Therapeutics, Inc. Chimeric polynucleotides
US20170210788A1 (en) 2014-07-23 2017-07-27 Modernatx, Inc. Modified polynucleotides for the production of intrabodies
CA2971520C (en) 2014-12-23 2024-04-09 Ilya Pharma Ab Methods for wound healing
CA2980562A1 (en) * 2015-03-25 2016-09-29 The General Hospital Corporation Digital analysis of circulating tumor cells in blood samples
GB201507030D0 (en) * 2015-04-24 2015-06-10 Immatics Biotechnologies Gmbh Immunotherapy against lung cancers, in particular NSCLC
TWI794761B (en) 2015-08-28 2023-03-01 德商英麥提克生物技術股份有限公司 Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
US20170136108A1 (en) 2015-08-28 2017-05-18 Immatics Biotechnologies Gmbh Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
GB201515321D0 (en) * 2015-08-28 2015-10-14 Immatics Biotechnologies Gmbh Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
EP3532642B1 (en) 2016-10-27 2021-12-08 The General Hospital Corporation Digital analysis of blood samples to determine efficacy of cancer therapies for specific cancers
KR20210041580A (en) 2018-08-02 2021-04-15 노파르티스 아게 New myokines and their uses
CN109706165A (en) * 2018-12-24 2019-05-03 杭州师范大学 The lactic acid bacteria excretion vector and its construction method, application of recombinant screen can be realized in Escherichia coli
CN110064045B (en) * 2019-05-15 2022-12-23 苏州大学 Application of micro-peptide CIP2A-BP in treating cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733762B1 (en) 1995-05-02 1997-08-01 Genset Sa METHOD FOR THE SPECIFIC COUPLING OF THE HAIR OF THE 5 'END OF A RNAM FRAGMENT AND PREPARATION OF RNAM AND COMPLETE DNA
AU7301698A (en) * 1996-11-22 1998-06-10 Human Genome Sciences, Inc. Thermostable polymerases having altered fidelity
US6110899A (en) * 1997-02-28 2000-08-29 Smithkline Beecham Corporation LICC of Streptococcus pneumoniae
WO2000061623A1 (en) * 1999-04-09 2000-10-19 Human Genome Sciences, Inc. 62 human secreted proteins
JP2002506627A (en) 1998-03-19 2002-03-05 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド 95 human secreted proteins
JP2002511259A (en) 1998-04-09 2002-04-16 ジェンセット 5 'ESTs and encoded human proteins

Similar Documents

Publication Publication Date Title
EP1076090A3 (en) ESTs and encoded human proteins
EP1076090A2 (en) ESTs and encoded human proteins
AU5721798A (en) Human mage-like protein
AU715620C (en) Therapeutic methods and uses
AU1608201A (en) Human zven proteins
AU3574900A (en) Human cervical cancer 1 protooncogene and protein encoded therein
AU4480697A (en) Human nm23-like protein
AU2067501A (en) Human oxidoreductase proteins
AU1626101A (en) Human transcriptomes
AU5475199A (en) Human chordin-related proteins and polynucleotides encoding them
AU9017598A (en) Human frezzled-like protein
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU8747098A (en) Human galectin-9-like proteins and cdnas encoding these proteins
AU2136401A (en) P450rai-2 and related proteins
AU2001245367A1 (en) Human transporter genes and proteins encoded thereby
AU2593199A (en) Human smn-like protein
AU4992099A (en) Human presenilin-associated protein
AU4151597A (en) Human dbi/acbp-like protein
AU7600598A (en) Human metaxin protein
AU5760200A (en) Human genes and proteins encoded thereby
AU7259898A (en) Human smt-3 like protein
AU2076701A (en) Novel human transporter protein and polynucleotides encoding the same
AU5309500A (en) Novel human genes and proteins encoded thereby
AU2002233265A1 (en) Human caplain proteins and polynucleotides coding therefor
AU2002345407A1 (en) Human cervical cancer 5 protooncogene and protein encoded therein

Legal Events

Date Code Title Description
AK Designated contracting states:

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Extension of the european patent to

Free format text: AL;LT;LV;MK;RO;SI

17P Request for examination filed

Effective date: 20011128

AKX Payment of designation fees

Free format text: AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report

Effective date: 20030710

RAP1 Applicant reassignment (correction)

Owner name: GENSET

RAP1 Applicant reassignment (correction)

Owner name: SERONO GENETICS INSTITUTE S.A.

RAP1 Applicant reassignment (correction)

Owner name: SERONO GENETICS INSTITUTE S.A.

18R Refused

Effective date: 20050127